193 related articles for article (PubMed ID: 25403427)
1. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.
Al-Moghrabi N; Nofel A; Al-Yousef N; Madkhali S; Bin Amer SM; Alaiya A; Shinwari Z; Al-Tweigeri T; Karakas B; Tulbah A; Aboussekhra A
BMC Cancer; 2014 Nov; 14():830. PubMed ID: 25403427
[TBL] [Abstract][Full Text] [Related]
2. Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters.
Al-Moghrabi N; Al-Showimi M; Al-Yousef N; Al-Shahrani B; Karakas B; Alghofaili L; Almubarak H; Madkhali S; Al Humaidan H
Clin Epigenetics; 2018 Jul; 10(1):99. PubMed ID: 30049288
[TBL] [Abstract][Full Text] [Related]
3. Constitutional
Al-Moghrabi N; Al-Showimi M; Alqahtani A; Almalik O; Alhusaini H; Almalki G; Saad A; Alsunayi E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542081
[TBL] [Abstract][Full Text] [Related]
4. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated
Al-Showimi M; Al-Yousef N; Alharbi W; Alkhezayem S; Almalik O; Alhusaini H; Alghamdi A; Al-Moghrabi N
Oncol Lett; 2022 Aug; 24(2):276. PubMed ID: 35782895
[TBL] [Abstract][Full Text] [Related]
6. Methylation Analysis of BRCA1 and APC in Breast Cancer and It's Relationship to Clinicopathological Features.
Shakeri H; Fakhrjou A; Nikanfar A; Mohaddes-Ardebili SM
Clin Lab; 2016 Dec; 62(12):2333-2337. PubMed ID: 28164568
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.
Otani Y; Miyake T; Kagara N; Shimoda M; Naoi Y; Maruyama N; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Cancer Sci; 2014 Oct; 105(10):1369-76. PubMed ID: 25155055
[TBL] [Abstract][Full Text] [Related]
8. Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.
Wong EM; Southey MC; Fox SB; Brown MA; Dowty JG; Jenkins MA; Giles GG; Hopper JL; Dobrovic A
Cancer Prev Res (Phila); 2011 Jan; 4(1):23-33. PubMed ID: 20978112
[TBL] [Abstract][Full Text] [Related]
9. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer.
Felicio PS; Melendez ME; Arantes LM; Kerr LM; Carraro DM; Grasel RS; Campacci N; Scapulatempo-Neto C; Fernandes GC; de Carvalho AC; Palmero EI
Oncotarget; 2017 Jan; 8(2):2850-2862. PubMed ID: 27926510
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
Harahap WA; Sudji IR; Nindrea RD
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
[TBL] [Abstract][Full Text] [Related]
12. RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families.
Larsen MJ; Thomassen M; Tan Q; Lænkholm AV; Bak M; Sørensen KP; Andersen MK; Kruse TA; Gerdes AM
BMC Med Genomics; 2014 Jan; 7():9. PubMed ID: 24479546
[TBL] [Abstract][Full Text] [Related]
13. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
Hasan TN; Leena Grace B; Shafi G; Syed R
Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
[TBL] [Abstract][Full Text] [Related]
14. Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.
Hsu NC; Huang YF; Yokoyama KK; Chu PY; Chen FM; Hou MF
PLoS One; 2013; 8(2):e56256. PubMed ID: 23405268
[TBL] [Abstract][Full Text] [Related]
15. Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patient.
Cai FF; Chen S; Wang MH; Lin XY; Zhang L; Zhang JX; Wang LX; Yang J; Ding JH; Pan X; Shao ZM; Biskup E
Oncotarget; 2016 May; 7(19):27499-510. PubMed ID: 27027444
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.
Iwamoto T; Yamamoto N; Taguchi T; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2011 Aug; 129(1):69-77. PubMed ID: 20882403
[TBL] [Abstract][Full Text] [Related]
17. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
18. Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan.
Muhammad N; Azeem A; Bakar MA; Prajzendanc K; Loya A; Jakubowska A; Hamann U; Rashid MU
Breast Cancer Res Treat; 2023 Nov; 202(2):377-387. PubMed ID: 37528266
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307
[TBL] [Abstract][Full Text] [Related]
20. Extent of breast cancer type 1 promoter methylation correlates with clinicopathological features in breast cancers.
Sun MY; Chang XZ; Xu GY; Dong Y; Zhou ZJ; Liu T; Wang CQ; Li YS
J Cancer Res Ther; 2018 Jun; 14(Supplement):S354-S361. PubMed ID: 29970689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
